These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5977540)

  • 1. Clinical trial of compound 1029 (vatensol).
    Srivastava BN; Gupta RK; Harshvardhan ; Goswami SL
    Indian Heart J; 1966 Oct; 18(4):333-44. PubMed ID: 5977540
    [No Abstract]   [Full Text] [Related]  

  • 2. Further observations on a new antihypertensive Vatensol (Compound 1029).
    Srivastava BN; Vyas GP; Tiwari AK; Tapa RS; Nema HS
    Indian Heart J; 1967 Oct; 19(4):329-35. PubMed ID: 4870899
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical assessment of the new antihypertensive Compound--1029 (Vatensol)--Guanoclor.
    Mehta AB; Biswas AK; Pinto IJ; Sheth UK
    Indian Heart J; 1967 Oct; 19(4):322-8. PubMed ID: 4870898
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial of a new antihypertensive agent associating Guanoxan sulfate with a thiazide diuretic].
    Linquette M; May JP; Cappoen JP
    Lille Med; 1972 Feb; 17():Suppl 2:183-6. PubMed ID: 5034400
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical trial of guanoxan alone and in combination with polythiazide in hypertension.
    Dave BT; Munsi CP; Bhakta RD; Parikh HM; Gulati OD
    Indian Heart J; 1970 Apr; 22(2):83-94. PubMed ID: 5524437
    [No Abstract]   [Full Text] [Related]  

  • 6. [Guanfacine: controlled clinical study in arterial hypertension].
    Lauro R
    Clin Ter; 1980 May; 93(4):439-55. PubMed ID: 6998644
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study and evaluation of a new guanidine derivative: "Ciclazenine" in the therapy of arterial hypertension].
    Del Guercio R; Valva M; Conti G; Savarese A; Piemontese M
    Rass Int Clin Ter; 1969 May; 49(10):591-604. PubMed ID: 5784806
    [No Abstract]   [Full Text] [Related]  

  • 8. [A clinical trial of guanoxabenz: a hypotensive agent with central and hypertensive action (author's transl)].
    Ledoux F; Welsch M; Steimer C; Schwartz J
    Therapie; 1981; 36(2):187-91. PubMed ID: 7027519
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical observations on the treatment of arterial hypertension with a new drug of a guanidine type: cyclazenine].
    Montagnani M; Bayelli PF; Antonelli A; Barducci O
    Clin Ter; 1968 Sep; 46(5):419-38. PubMed ID: 5747193
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ciclazenine in the therapy of arterial hypertension].
    Busilacchi M; Perpignano G; Altieri P; Verzetti G
    Rass Int Clin Ter; 1969 May; 49(10):605-14. PubMed ID: 5784807
    [No Abstract]   [Full Text] [Related]  

  • 11. [The broad-spectrum antihypertensive agent Tadip in slight and moderate hypertension].
    Kempf E
    Med Monatsschr; 1968 Jun; 22(6):270-5. PubMed ID: 5720912
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of arterial hypertension by guanoxan].
    França HH; Simão J; Baroni R
    Rev Paul Med; 1967 Apr; 70(4):172-8. PubMed ID: 5614421
    [No Abstract]   [Full Text] [Related]  

  • 13. [Betanidine (Esbatal, Regulin) in the therapy of hypertension].
    Vejlsgaard V
    Ugeskr Laeger; 1968 Jan; 130(4):134-6. PubMed ID: 5674763
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy of guanfacine in the treatment of arterial hypertension].
    de Broucker D; Graux P; Dutoit A; Croccel L
    LARC Med; 1982; 2(7):613-5. PubMed ID: 6762476
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cyclazenin in the treatment of arterial hypertension].
    Salvetti A; Romanelli R
    Policlinico Prat; 1969 Jun; 76(24):777-82. PubMed ID: 5404717
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new drug in the medical treatment of arterial hypertension: cyclazenin].
    Mameli P; Maioli M; Fanzecu P
    Rass Int Clin Ter; 1970 Apr; 50(8):457-64. PubMed ID: 4394494
    [No Abstract]   [Full Text] [Related]  

  • 18. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
    Mayer K; Lupínek Z; Janousek S; Podrouzková B
    Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N; Knaup G
    Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of arterial hypertension with polythiazide and guanoxan].
    Froment A; Vallese J
    Lyon Med; 1969 Mar; 221(10):523-7. PubMed ID: 5357282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.